Clinical Trial Update: Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating Injectable Collagen Scaffold™ combined with human umbilical cord mesenchymal stem cells for decompensated cirrhosis. Status curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• Injectable Collagen Scaffold™ combined with HUC-MSCs

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Decompensated Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN